REGENXBIO Inc.
RGNX
$6.72
$0.172.60%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
3/14/2025
-
MarketBeat
3/14/2025
-
TipRanks Financial Blog
3/14/2025
-
The Fly
3/14/2025
-
Tickeron - Stocks
3/14/2025
-
GuruFocus
3/14/2025
-
GuruFocus
3/13/2025
-
SeekingAlpha
3/13/2025
-
Seeking Alpha: Transcripts
3/13/2025
-
GuruFocus
3/13/2025
-
Zacks Investment Research
REGENXBIO Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Operational Updates
3/13/2025
-
GuruFocus
3/13/2025
-
The Fly
REGENXBIO Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Operational Updates
3/13/2025
-
PR Newswire
3/13/2025
-
Tickeron - Stocks
3/13/2025
-
Tickeron - Stocks
3/12/2025
-
Tickeron - Stocks
3/11/2025
-
Tickeron - Stocks
3/11/2025
-
Tickeron - Stocks
3/10/2025
-
GuruFocus
3/10/2025
-
PR Newswire
3/8/2025
-
Tickeron - Stocks
3/8/2025
-
MarketBeat
3/7/2025
-
MarketBeat
3/6/2025
-
Tickeron - Stocks
3/6/2025
-
Tickeron - Technical Analysis
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, November 6, 2024
Period Date
Monday, September 30, 2024
Next Filing
Week of Feb 24 and 28 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
240 552 8181
Address
9804 Medical Center Drive
Rockville, MD 20850
Rockville, MD 20850
Country
Year Founded
Business Description
Sector
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States. Its gene therapy product...
more